Gastrointestinal infections in the immunocompromised host

Current Opinion in Gastroenterology

Volumn 17, Issue 1, 2001, Pages 40-45

  Fantry, L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE;

ANTIMICROBIAL THERAPY; CANDIDIASIS; CLINICAL TRIAL; DISEASE SEVERITY; GASTROINTESTINAL INFECTION; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; LARGE INTESTINE; MORBIDITY; MORTALITY; OPPORTUNISTIC INFECTION; PATHOGENESIS; QUALITY OF LIFE; REVIEW; SMALL INTESTINE; STOMACH DISEASE;

EID: 0035144712     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200101000-00008     Document Type: Review

References (61)

1. AIDS across europe, 1994-98: The EuroSIDA study
2. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy
3. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis
4. Characterization of intestinal disease associated with human immunodeficiency virus infection and response to antiretroviral therapy
5. Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea
6. Enteric infections and diarrhea in human immunodeficiency virus-infected persons: Prospective community-based cohort study. Swiss HIV Cohort Study
7. Prognostic factors correlated with survival in AIDS patients
8. Shorter survival in HIV-positive patients with diarrhoea who excrete adenovirus from the GI tract
9. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy
10. Treatment of fluconazole-refractory oropharyngeal candidiasis with traconazole oral solution in HIV-positive patients
11. Prevalence and etiology of gastroduodenal ulcer in HIV-positive patients: A comparative study of 497 symptomatic subjects evaluated by endoscopy
12. Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal pain
13. Massive upper gastrointestinal hemorrhage due to cytomegalovirus infection in two patients with acquired immunodeficiency syndrome
14. Possible association between cytomegalovirus infection and gastrointestinal bleeding in hemophiliac patients
15. Cytomegalovirus infection of the human gastrointestinal tract
16. The pathologic spectrum of gastrointestinal and hepatic histoplasmosis
17. Zygomycetes in human disease
18. Impact of protease inhibitors on the outcome of human immunodeficiency virus-infected patients witn chronic diarrhea
19. HIV and diarrhea in the era of HAART: 1998 New York state hospitalizations
20. Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection
21. Diarrhea and enteric emerging viruses in HIV-infected patients
22. Diagnostic yield and cost-effectiveness of endoscopy in chronic human immunodeficiency virus-related diarrhea
23. Endoscopic evaluation of chronic human immunodeficiency virus-related diarrhea: Is colonoscopy superior to flexible sigmoidoscopy?
24. Endoscopy in acquired immunodeficiency syndrome patients with diarrhea and negative stool studies
25. Intestinal involvement by nontuberculous mycobacteria after heart transplantation
26. Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1 -infected monocytes/macrophages in vitro and in vivo
27. Introduction to the 1999 USPHA/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
28. Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents
29. Active intestinal tuberculosis with esophageal candidiasis due to idiopathic CD4(+) T-lymphocytopenia in an elderly woman
30. Gastrointestinal mucormycosis complicated by arterioenteric fistula in a patient with non-Hodgkin's lymphoma
31. Endoscopic diagnosis of intestinal Penicilliosis marneffei: Report of three cases and review of the literature
32. Clinical prediction model for differentiation of disseminated Histoplasma capsulatum and Mycobacterium avium complex infections in febrile patients with AIDS
33. Intestinal protozoa in HIV-infected patients in Apulia, South Italy
34. Intestinal protozoa in HIV-infected patients: Effect of rifaximin in Cryprosporidium parvum and Blastocystis hominis infections
35. Cryptosporidium and Isospora belli diarrhoea in immunocompromised hosts
36. Prevalence of intestinal parasitic infections in patients with acquired immunodeficiency syndrome in Brazil
37. Intestinal protozoa in HIV-infected patients: Effect of rifaximin in Cryptosporidium parvum and Blastocystis hominis infections
38. Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1
39. Intestinal microsporidiosis occurring in two renal transplant recipients treated with mycophenolate mofetil
40. Natural history of intestinal microsporidiosis among patients infected with human immunodeficiency virus
41. The diagnostic value of electron microscopy in human immunodeficiency virus-positive patients with gastrointestinal disease
42. Production of monoclonal antibodies directed against the microsporidium Enterocytozoon bieneusi
43. Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: Results of a drug screening study
44. TNP-470 is an effective antimicrosporidial agent
45. Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS
46. Trimethoprimsulfamethoxazoie compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial
47. Digestive leishmaniasis in acquired immunodeficieney syndrome: A light and electron microscopic study of two cases
48. The histological spectrum of visceral leishmaniasis caused by Leishmania infantum MON-1 in acquired immune deficiency syndrome
49. Clinical manifestations of visceral leishmaniasis associated with HIV infection: A retrospective study of 91 French cases
50. Leishmaniasis
51. Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts
52. Cytomegaloviral enterocolitis: Clinical associations and outcome
53. Cytomegalovirus colitis presenting with the endoscopic appearance of pseudomembranous colitis
54. Investigation of chronic diarrhoea in acquired immunodeficiency syndrome. A prospective study of 155 patients
55. Adenovirus infection of the large bowel in HIV positive patients
56. Adenovirus colitis in human immunodeficiency virus infection: An underdiagnosed entity
57. High prevalence of diarrhea but infrequency of documented Clostndium difficile in autologous peripheral blood progenitor cell transplant recipients
58. Clostridium difficile colitis after kidney and kidney-pancreas transplantation
59. A clinicopathologic analysis of AIDS-related cryptosporidiosis
60. Severe gastrointestinal hemorrhage due to Mycobacterium avium complex in a patient receiving immunosuppressive therapy
61. HIV infection as a risk factor for shigellosis